Quote For Cephalon, Inc. CEPH.O
Cephalon, Inc. (CEPH.O) (Nasdaq)
sector: Healthcare ·
industry: Biotechnology ·
$55.23
27 Nov 2009
-1.20%
$55.90
$54.44
970,247
$55.85
$54.70
$81.35
$52.55
0.47
3,244,202
News
Press Releases
Key Developments
Officers
| Name | Current Position | Compensation |
|---|---|---|
| Baldino, Frank | Chairman of the Board, Chief Executive Officer | 14,496,500 |
| Buchi, J. Kevin | Chief Financial Officer, Executive Vice President | 3,378,460 |
| Savini, Carl | Executive Vice President, Chief Administrative Officer | 3,387,820 |
Key Ratios and Statistics
| Share Related Items | |
|---|---|
| Market Cap (Mil.) | $4,123.40 |
| Shares Outstanding (Mil.) | 74.66 |
| Float (Mil.) | 74.10 |
| Dividend Information | |
|---|---|
| Yield % | -99,999.99 |
| Annual Dividend ($ USD) | 0.00 |
| Payout Ratio(TTM) % | 0.00 |
| Financial Strength | |
|---|---|
| Quick Ratio | 0.85 |
| Current Ratio | 1.89 |
| LT Debt/Equity | 16.68 |
| Total Debt/Equity | 54.47 |
| Valuation Ratios | |
|---|---|
| Price/Earnings(TTM) | 16.66 |
| Price/Sales(TTM) | 1.91 |
| Price/Book(TTM) | 1.92 |
| Price/Cash Flow(TTM) | 10.81 |
| Per Share Data | |
|---|---|
| Earnings(TTM) | $3.59 |
| Sales(TTM) | $27.76 |
| Book Value(MRQ) | $28.71 |
| Cash Flow(TTM) | $4.91 |
| Cash(MRQ) | $21.23 |
| Management Effectiveness | |
|---|---|
| Return on Equity(TTM) | 13.87 |
| Return on Assets(TTM) | 4.85 |
| Return on Investment(TTM) | 8.24 |
| Margins | |
|---|---|
| Gross Margin(TTM) % | 81.49 |
| Operating Margin(TTM) % | 14.84 |
| Profit Margin(TTM) % | 9.34 |
Market Update
UK
US- Europe
- Asia
- UK Most Actives
advertisement
